Description  | 1
Day Price Change % | Market Cap | P/E | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq) | Price to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | -0.52 | 2170.0B | 20.35 | 13.94 | 2.28 | 0.86 | 10.07 | 11.43 | 572.96 |
| Industry: Drug Manufacturers - Major (More Info) | -0.24 | 1070.5B | 16.20 | 19.50 | 3.75 | 0.45 | 9.49 | 16.70 | -243.60 |
| Companies | |||||||||
| Abbott Laboratories (ABT) | 3.07 | 84.0B | 22.07 | 23.82 | 2.70 | 0.73 | 4.67 | 13.86 | 116.67 |
| Aceto Corp. (ACET) | -0.87 | 194.7M | 24.08 | 6.59 | 2.50 | 0.00 | 1.51 | 1.18 | 80.50 |
| AP Pharma Inc. (APPA) | -4.29 | 41.3M | NA | -95.54 | NA | NA | 1.40 | NA | -18.14 |
| APP Pharmaceuticals, Inc. (APPX) | -1.75 | 1.9B | 55.26 | 17.24 | NA | NA | NA | 4.39 | NA |
| Applied Wellness Corp. (AWLL.OB) | NA | NA | NA | NA | NA | NA | NA | 22.34 | NA |
| AstraZeneca plc (AZN) | -0.68 | 59.3B | 10.87 | 38.69 | 4.60 | 1.02 | 4.03 | 19.58 | -235.03 |
| Bristol-Myers Squibb Co. (BMY) | -0.14 | 42.8B | 20.06 | 19.46 | 5.70 | 0.61 | 4.05 | 12.76 | 50.38 |
| Callisto Pharmaceuticals, Inc. (KAL) | -3.57 | 12.7M | NA | -596.74 | NA | NA | 7.11 | NA | 1.80 |
| Chem Rx Corporation (CHRX.OB) | NA | NA | NA | 4.27 | NA | 2.10 | NA | 2.28 | NA |
| Eli Lilly & Co. (LLY) | -1.53 | 52.0B | 14.79 | NA | 3.90 | 0.37 | 3.95 | 22.14 | NA |
| Evotec AG (EVTC) | 3.07 | 322.7M | NA | -28.36 | NA | 0.07 | 1.22 | 91.71 | NA |
| GeoPharma Inc. (GORX) | -1.87 | 37.5M | NA | -12.61 | NA | 0.61 | 1.08 | -8.64 | -18.11 |
| Glaxosmithkline plc (GSK) | -1.00 | 115.5B | 12.27 | 53.12 | 4.70 | 1.11 | 6.62 | 22.99 | 33.45 |
| Inhibiton Therapeutics, Inc. (IHBT.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Javelin Pharmaceuticals, Inc. (JAV) | -1.04 | 139.8M | NA | -117.67 | NA | NA | 4.05 | NA | -22.56 |
| Johnson & Johnson (JNJ) | -0.45 | 190.4B | 16.57 | NA | 2.80 | 0.22 | 4.35 | 22.22 | NA |
| Keryx Biopharmaceuticals Inc. (KERX) | 10.87 | 22.3M | NA | -107.06 | NA | NA | 0.50 | NA | 10.24 |
| Merck & Co. Inc. (MRK) | -1.14 | 84.1B | 17.61 | 25.65 | 3.80 | 0.23 | 4.31 | 56.73 | -79.54 |
| Minrad International Inc. (BUF) | -6.81 | 86.8M | NA | -71.50 | NA | 0.42 | 4.54 | -223.16 | 980.88 |
| Neurologix Inc. (NRGX.OB) | 1.56 | 18.0M | NA | -43.95 | NA | NA | 0.89 | NA | -19.14 |
| Novartis AG (NVS) | -0.88 | 114.6B | 9.62 | 14.99 | 2.90 | 0.13 | 2.33 | 22.68 | 510.40 |
| Novogen Limited (NVGN) | -0.77 | 150.5M | NA | -41.62 | NA | NA | 3.80 | -140.78 | -39.08 |
| Oscient Pharmaceuticals Corp. (OSCI) | 6.44 | 29.6M | NA | NA | NA | NA | NA | -58.01 | -3.27 |
| Pfizer Inc. (PFE) | 0.30 | 135.1B | 18.19 | 10.92 | 6.40 | 0.25 | 2.01 | 23.50 | -210.23 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | 0.00 | 58.1M | NA | -65.93 | NA | NA | 3.90 | NA | -40.64 |
| Quick-Med Technologies Inc. (QMDT.OB) | -3.33 | 8.9M | NA | NA | NA | NA | NA | -201.17 | -54.12 |
| Rigel Pharmaceuticals, Inc. (RIGL) | -0.22 | 830.4M | NA | -87.68 | NA | 0.02 | 8.69 | -237.53 | -165.16 |
| Sanofi-Aventis (SNY) | 0.05 | 97.9B | 12.79 | NA | 2.70 | 0.13 | 1.42 | 25.80 | NA |
| Schering-Plough Corp. (SGP) | 1.01 | 30.7B | NA | NA | 1.40 | 0.91 | 3.89 | 6.25 | NA |
| Spectrum Pharmaceuticals, Inc. (SPPI) | 3.95 | 57.5M | NA | -71.97 | NA | NA | 1.21 | NA | -7.23 |
| Tetragenex Pharmaceuticals, In (TTRXE.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Vertical Health Solutions Inc. (VHSL.OB) | 0.00 | 0.3M | NA | NA | NA | NA | NA | NA | NA |
| WuXi PharmaTech (Cayman) Inc. (WX) | 0.98 | 1.2B | 45.99 | 22.63 | NA | 0.18 | 4.77 | 32.70 | NA |
| Wyeth (WYE) | -1.05 | 59.2B | 13.26 | 26.56 | 2.50 | 0.60 | 3.07 | 20.96 | -241.01 |